Development of an Algorithm to Detect Pulmonary Hypertension Using an Electronic Stethoscope
Eko Devices, Inc. · NCT05873387
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 2420
- US sites recruiting
- 1
- Study start
- July 12, 2023
- Record last updated
- August 24, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The major goal of the study is to determine whether phonocardiography (using the Eko DUO stethoscope which can capture a three lead ECG reading) can present features that relate to the presence of PH diagnosed by echocardiography or right heart catheterization (RHC), and therefore have a potential to assist the provider to suspect PH.
Being studied: Use of Eko DUO stethoscope (paired ECG/PCG)
Conditions: Pulmonary Hypertension
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Patients, ages >18 years, referred for complete 2-dimensional echocardiography or right heart catheterization will be screened for inclusion.
Exclusion Criteria
- Patients undergoing limited echocardiography
- Intubated patients
Recruiting US locations
Providence VA Medical Center
Providence, RI 02908
Site contact: Pamela Brewer, PhD, RN · 401-273-71oo · Pamela.Brewer2@va.gov
Study contacts (from the official record)
- Spencer Kieu · 714-623-6652 · spencer.kieu@ekohealth.com
Similar studies in Rhode Island
All heart & blood pressure studies in Rhode Island →- Recruiting
Prevail Global Study
Medtronic Vascular
- Location
- Providence, RI + 53 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary Lesions
Boston Scientific Corporation
- Location
- Providence, RI + 46 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
AstraZeneca
- Location
- Providence, RI + 93 other US sites
- Eligibility basics
- Ages 18–130
- RecruitingPhase 1/Phase 2
A Study of HS235 for Treatment of Pulmonary Arterial Hypertension (PAH) in Adults
35Pharma Inc
- Location
- Providence, RI + 1 other US site
- Eligibility basics
- Ages 18+